Nanoparticles Increase Lung Cancer Drug Delivery 30-fold
Researchers at Adelaide University developed a lipid-polymer vehicle that improves drug bioavailability and reduces systemic toxicity in preclinical models of lung cancer.
Tag: lung cancer
All
Latest
Nanoparticles Increase Lung Cancer Drug Delivery 30-fold
Researchers at Adelaide University developed a lipid-polymer vehicle that improves drug bioavailability and reduces systemic toxicity in preclinical models of lung cancer.
Read More
Smart Biopsy Tool Technology Improves Lung Cancer Detection
A smart sensor integrated into a biopsy device helps clinicians identify cancerous tissue in real time to improve diagnostic results.
Read More
Double-Lung Transplant Successfully Treats Terminal Lung Cancer
A patient with advanced lung cancer and interstitial lung disease received a double-lung transplant through a clinical trial at Northwestern Medicine.
Read More
New CRISPR Can Shred Infected Cells’ DNA
Researchers have developed a new form of CRISPR technology that destroys harmful cells instead of editing their genes, while leaving healthy tissue untouched.
Read More
Protein Linked to Chemotherapy Resistance in Lung Cancer
A study found that YAP1 protein expression emerges after treatment, contributing to relapse in small cell lung cancer patients.
Read More
Pesticide Exposure via Healthy Diets May Increase Lung Cancer Risk in Young Nonsmokers
New research suggests that pesticide residues on fruits, vegetables, and whole grains may contribute to an increase in lung cancer cases among Americans under age 50 who have never smoked.
Read More
Ai Predicts Chemo Response in Small Cell Lung Cancer
A new computational biomarker uses existing biopsy slides to identify which patients will benefit from standard treatment before therapy begins.
Read More
Ai Predicts Chemotherapy Response in Lung Cancer Patients
An artificial intelligence tool called PhenopyCell can determine if patients with extensive-stage small cell lung cancer will benefit from chemotherapy using existing biopsy slides.
Read More
Researchers ID Genetic Target for Aggressive Lung Cancers
UCLA study finds that small cell neuroendocrine tumors depend on a specific protein to grow, offering a potential path for new treatments.
Read More
Lung Cancer Screening Initiative for Indigenous Communities
A three-year grant will provide lung cancer screening resources, wellness education, and patient navigation to Tribal Nations across North America.
Read More
Study Strengthens Evidence for Pleurectomy / Decortication for Mesothelioma
Pleurectomy/decortication, a lung-sparing surgery, can be performed safely with low mortality in carefully selected patients with pleural mesothelioma.
Read More
WHO: 37% of Cancer Cases Preventable
WHO examines 30 preventable causes of cancer, including tobacco, alcohol, high BMI, air pollution, UV radiation and cancer-causing infections.
Read More
Misinformation Preventing CT Lung Cancer Screenings
Confusion over false positive rates, overstated complication risks, and inflated radiation danger projections have created exaggerated fears about CT lung cancer screenings.
Read More
First US Patient Treated with New Lung Cancer Therapy
UK Markey Cancer Center is the first site in the country to open a clinical trial for ZG006 (Alveltamig), an experimental drug that works by connecting disease-fighting T cells to cancer cells, allowing the body’s immune system to attack the cancer.
Read More
FT-IR Microspectroscopy Detects Single Lung Cancer Cell
The FT-IR microspectroscopy blood test detected a single circulating tumor cell (CTC) in one patient with lung cancer using cytospun raw blood samples.
Read More
Diagnostic Follow-up on Positive Lung Cancer Screening Misses Mark
Diagnostic follow-up after positive lung cancer screening falls short of guidelines, with 60% of patients receiving proper care.
Read More
Lung Screenings Based on Smoking Duration May Reduce Racial Disparities in Lung Cancer Detection
Smoking duration–based criteria may offer a viable alternative to pack-year based screening.
Read More
Eligible Women Receiving Mammograms Could Also Get Lung Screenings
Notifying women of their eligibility for low-dose CT scans for lung cancer while they are scheduling mammograms for breast cancer could increase lung screenings.
Read More
FDA Approves Hyrnuo (sevabertinib) for Certain NSC Lung Cancer Patients
Hyrnuo is now indicated for adult patients with locally advanced or metastatic non-squamous NSCLC whose tumors have HER2 (ERBB2) TKD activating mutations, as detected by an FDA-approved test, and who have received a prior systemic therapy.
Read More
Only 20% of Eligible Americans Screened for Lung Cancer
New data published in JAMA reveal only 1-in-5 eligible US adults receive lung cancer screening.
Read More
Lung Association Releases 2025 State of Lung Cancer Report
The American Lung Association has released its 2025 “State of Lung Cancer” report, which shows progress in coverage of comprehensive biomarker testing for lung cancer.
Read More
US Tobacco Atlas Now Available
The inaugural US Tobacco Atlas reveals that cigarette smoking in American adults has dropped from 42% in 1965 to 11% in 2023.
Read More
Lung Cancer: California Ranks Among Best in Nation in Diagnoses, 5-yr Survival
California ranks third in the nation for rate of new lung cancer cases and 10th in the nation for survival.
Read More
Cancer Survival Benefits for Patients Receiving mRNA-based COVID-19 Vaccines
Commercially available mRNA COVID-19 vaccines can train patients’ immune systems to eliminate cancer, according to data presented at ESMO 2025.
Read More